Showing results (2481-2490 of 9,905) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|June 16, 2010
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCTN Cantoni, S Gerull, D Heim, et al.Bone Marrow Transplantation|June 16, 2010
Prognostic factors in allo-SCT of elderly patients with AMLJ Krauter, K Wagner, M Stadler, et al.Bone Marrow Transplantation|March 1, 1991
Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxisH J Deeg, T R Spitzer, M Cottler-Fox, et al.Bone Marrow Transplantation|October 20, 2010
Paraproteinaemia after allo-SCT, association with alemtuzumab-based conditioning and CMV reactivationP Medd, S Littlewood, R Danby, et al.Bone Marrow Transplantation|May 1, 1991
Persistence of murine myeloid leukaemic cells in long-term bone marrow culturesA C Riches, M Hepburn, J Melville, et al.Bone Marrow Transplantation|May 1, 1991
Autologous bone marrow processing for autotransplantation using an automated cell processor and a semiautomated procedureL Pierelli, G Menichella, R Serafini, et al.Bone Marrow Transplantation|May 1, 1991
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3C Anasetti, P J Martin, R Storb, et al.Bone Marrow Transplantation|May 1, 1991
Donor-HLA-incompatible marrow transplantation with an anti-donor cytotoxic antibody in the serum of the patientA Maruta, H Fukawa, H Kanamori, et al.Bone Marrow Transplantation|August 17, 2010
Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibilityY Wang, L P Xu, K Y Liu, et al.Bone Marrow Transplantation|April 1, 1991
Bone marrow transplantation for chronic lymphocytic leukemiaG Bandini, M Michallet, G Rosti, et al.Pageof 991